Advertisement
|
|
news roundup
TrialScope, a company specializing in clinical trial transparency and compliance solutions, announced the launch of its Clinical Trial Transparency Service (CTTS) for sponsors. The new service hopes to improve patient engagement, lower costs, and increase transparency through a clinical trial publication website.
| advertisement
Text Ad - 1 heading
Text Ad content goes here
Learn more |
GB Sciences, Inc. and Catalent Pharma Solutions announced that GB Sciences has selected Catalent to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences' proprietary active pharmaceutical ingredients for its Parkinson's disease therapies.
| advertisement
Text Ad - 2 heading
Text Ad content goes here
Learn more |
Medidata announced that Decibel Therapeutics is adopting Medidata Cloud and specifically using its eTMF and eCOA/ePRO solutions. The agreement will support Decibel Therapeutics' clinical development for hearing loss, tinnitus, and balance disorders.
| advertisement
Text Ad - 3 heading
Text Ad content goes here
Learn more |
ActiGraph has announced the launch of its newest activity monitor, the CentrePoint Insight Watch. This watch hopes to deliver high quality, real-world data, and an enhance patient experiences during clinical drug trials and health research studies.
| advertisement
Text Ad - 4 heading
Text Ad content goes here
Learn more |
|
|
|
advertisement
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
| advertisement
Text Ad - 7 heading
Text Ad content goes here
Learn more |
|
Advertisement
|
|
Other News
LabCorp announced that its Covance Drug Development business will open a companion diagnostics lab in Morrisville, North Carolina. The facility also includes a genomics and molecular pathology lab to support clinical trials and diagnostic testing development, and houses manufacturing facilities for diagnostics materials and testing components.
| advertisement
Text Ad - 5 heading
Text Ad content goes here
Learn more |
In anticipation of relocating, the EMA has started on the re-distribution of the workload relating to the evaluation and monitoring of medicines to ensure the quality of EMAs scientific assessments and compliance with legal timelines
Additionally, the EMA announced that the EU clinical trial portal and database’s go-live date has been postponed, due to technical issues with the IT systems.
| advertisement
Text Ad - 6 heading
Text Ad content goes here
Learn more |
|
|
Articles
This study looks at in-office conversations earlier in the patient journey toward a clinical trial, before suitable trial options have been identified or patient eligibility for a study has been established. These early conversations set the stage for patients’ understanding of and receptivity toward enrolling in a clinical trial in the future.
| advertisement
Text Ad - 8 heading
Text Ad content goes here
Learn more |
This study looks at in-office conversations earlier in the patient journey toward a clinical trial, before suitable trial options have been identified or patient eligibility for a study has been established. These early conversations set the stage for patients’ understanding of and receptivity toward enrolling in a clinical trial in the future.
| advertisement
Text Ad - 9 heading
Text Ad content goes here
Learn more |
|
|
|
Oncology
The region is significantly underrepresented in clinical development activity targeting childhood cancer. |
|
|
With technology's increasing ability to gather and analyze previously unmanageable data sets, and medicine's forays into genomics and targeted therapies, the time of the master protocol may be at hand.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
